ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
RWE Continues to Shape the Future Clinical Research Landscape
The availability of big data is creating a shift in clinical research allowing researchers to make intelligent, strategic decisions based on real world evidence.
Role of ICER as an Independent HTA
Earlier monitoring of updates to ICER value frameworks and consideration of competitor and analog ICER assessments should be a priority
Tufts CSDD Study
Is your clinical partnership evolving to ensure sustained growth?
How RBM Is Changing The Role Of Monitors
How risk based monitoring is changing the role of monitors.
Why a Patient's Experience with a Drug Matters
Patient reported outcomes are often the primary endpoints in FDA approved pain drugs.
Challenges in Manufacturing and Distribution of CAR-T Therapies
ICON experts contribute to this Pharmafocus article on the challenges in the manufacturing and distribution of CAR-T therapies for patients.
Evaluation of Psoriasis Patient Attitudes in their Choice of Treatments
How psoriasis patients’ prior treatment history impacts future treatment choices.
Innovative CROs Support a More Integrated R&D Model
For the past decade, the pharma industry has been working to overcome what many called a “crisis” in R&D productivity.
Biomarkers in Oncology
ICON’s expert Mario Rocci talks to EBR about the use of biomarkers in oncology.
Change of Interoperability to Be Addressed
A panel discussion on the adoption of digital health and the key areas in which interoperability can become more dominant.